Skip to content
Screener

Tempest Therapeutics TPST Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

EPS-$0.62In line
EPS estimate-$0.62

Next report

Nov 4, 2026 (in 2 months)
EPS estimate-$0.35

FAQ

When did Tempest Therapeutics report Q4 2025 earnings?
Tempest Therapeutics (TPST) reported Q4 2025 earnings on March 31, 2026 before market open.
What were Tempest Therapeutics's Q4 2025 revenue and EPS?
Tempest Therapeutics reported eps of $-0.62 for Q4 2025.
Did Tempest Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.62 by $0.00.
How did Tempest Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 84.6% from $-4.03.
Where can I find Tempest Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-130480) and the 10-K periodic report (0001193125-26-130490) directly on SEC EDGAR. The filing index links above go to sec.gov.